Skip to Main Content
Try STAT+ TODAY
Trending:
The Obesity Revolution
Health
Biotech
First Opinion
The Readout

Tips for slashing drug prices & Kite’s big CAR-T gamble

  • Damian Garde
  • Meghana Keshavan

By Damian Garde and Meghana Keshavan Oct. 19, 2016

Reprints
The READOUT
Alex Hogan/STAT

The Readout for October 19, 2016

About the Authors Reprints

Damian Garde

Damian Garde

National Biotech Reporter

Damian Garde covers biotech, is a co-writer of The Readout newsletter, and a co-host of "The Readout LOUD" podcast.

Meghana Keshavan

Meghana Keshavan

Biotech Correspondent

Meghana Keshavan covers biotech and contributes to The Readout newsletter.

The X-waiver for buprenorphine prescribing is gone. It’s time…
The X-waiver for buprenorphine prescribing is gone. It’s time to spread the word
New guidelines on severe brain injury complicate already difficult…
New guidelines on severe brain injury complicate already difficult decisions
When death is imminent, end-of-life care decisions sometimes go…
When death is imminent, end-of-life care decisions sometimes go out the window
Regeneron targets obesity, a new microbiome deal, & comparing…
Regeneron targets obesity, a new microbiome deal, & comparing cancer drug costs
Should the feds investigate Aduhelm? Plus: biotech’s biggest binaries…
Should the feds investigate Aduhelm? Plus: biotech’s biggest binaries & regenerating heart tissue
Docs disagree with FDA on Aduhelm, Swiss giants pinch…
Docs disagree with FDA on Aduhelm, Swiss giants pinch pennies, & one SPAC makes it rain

Recommended Stories